Skip to main content
Erschienen in: Indian Journal of Surgical Oncology 4/2015

01.08.2015 | REVIEW ARTICLE

Bilateral Mastectomy for Unilateral Breast Cancer: a Perplexing Trend

verfasst von: Ismail Jatoi

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

In the United States, there has been a trend towards the increased utilization of bilateral mastectomy for the treatment of unilateral breast cancer. Yet, breast conserving surgery rates have increased slightly, so it is among women choosing mastectomy that the use of bilateral mastectomy is increasing. Ironically, since about 1985, the risk of developing contralateral breast cancer has decreased, likely due to the widespread use of adjuvant systemic therapy for the treatment of early breast cancer. The increased utilization of bilateral mastectomy is therefore puzzling, and this article discusses factors that may account for this trend. Several observational studies have shown that bilateral mastectomy is associated with improved survival when compared to unilateral mastectomy. However, these associations are probably due to selection bias, and bilateral mastectomy is unlikely to have an independent effect in improving survival for the majority of women with unilateral breast cancer. Bilateral mastectomy might be indicated for women with a high risk of developing contralateral breast cancer, such as those with a history of mantle irradiation or mutations in the BRCA 1 or BRCA 2 genes, but it cannot be entirely justified in the majority of women with unilateral breast cancer.
Literatur
1.
Zurück zum Zitat Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25(33):5203–5209CrossRefPubMed Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25(33):5203–5209CrossRefPubMed
2.
Zurück zum Zitat Neuburger J, Macneill F, Jeevan R, van der Meulen JH, Cromwell DA (2013) Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics. BMJ open 3(8). doi:10.1136/bmjopen-2013-003179 Neuburger J, Macneill F, Jeevan R, van der Meulen JH, Cromwell DA (2013) Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics. BMJ open 3(8). doi:10.​1136/​bmjopen-2013-003179
3.
Zurück zum Zitat Sim Y, Tan VK, Ho GH et al (2014) Contralateral prophylactic mastectomy in an Asian population: a single institution review. Breast 23(1):56–62CrossRefPubMed Sim Y, Tan VK, Ho GH et al (2014) Contralateral prophylactic mastectomy in an Asian population: a single institution review. Breast 23(1):56–62CrossRefPubMed
4.
Zurück zum Zitat Habermann EB, Abbott A, Parsons HM, Virnig BA, Al-Refaie WB, Tuttle TM (2010) Are mastectomy rates really increasing in the United States? J Clin Oncol 28(21):3437–3441CrossRefPubMed Habermann EB, Abbott A, Parsons HM, Virnig BA, Al-Refaie WB, Tuttle TM (2010) Are mastectomy rates really increasing in the United States? J Clin Oncol 28(21):3437–3441CrossRefPubMed
5.
Zurück zum Zitat Tuttle TM, Jarosek S, Habermann EB et al (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27(9):1362–1367CrossRefPubMed Tuttle TM, Jarosek S, Habermann EB et al (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27(9):1362–1367CrossRefPubMed
6.
Zurück zum Zitat Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL (2014) Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998–2011. JAMA 312(9):902–914CrossRefPubMed Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL (2014) Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998–2011. JAMA 312(9):902–914CrossRefPubMed
7.
Zurück zum Zitat Nichols HB, Berrington de Gonzalez A, Lacey JV Jr, Rosenberg PS, Anderson WF (2011) Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 29(12):1564–1569CrossRefPubMedPubMedCentral Nichols HB, Berrington de Gonzalez A, Lacey JV Jr, Rosenberg PS, Anderson WF (2011) Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 29(12):1564–1569CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Jatoi I, Chen BE, Anderson WF, Rosenberg PS (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25(13):1683–1690CrossRefPubMed Jatoi I, Chen BE, Anderson WF, Rosenberg PS (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25(13):1683–1690CrossRefPubMed
9.
Zurück zum Zitat Agarwal S, Kidwell K, Kraft CT et al (2014) A rising trend in use of contralateral prophylactic mastectomy: does the decision to undergo immediate reconstruction play a role? Plast Reconstr Surg 134(4 Suppl 1):87CrossRef Agarwal S, Kidwell K, Kraft CT et al (2014) A rising trend in use of contralateral prophylactic mastectomy: does the decision to undergo immediate reconstruction play a role? Plast Reconstr Surg 134(4 Suppl 1):87CrossRef
10.
Zurück zum Zitat Wood WC (2009) Should the use of contralateral prophylactic mastectomy be increasing as it is? Breast 18(Suppl 3):S93–S95CrossRefPubMed Wood WC (2009) Should the use of contralateral prophylactic mastectomy be increasing as it is? Breast 18(Suppl 3):S93–S95CrossRefPubMed
11.
Zurück zum Zitat Oseni T, Jatoi I (2008) An overview of the role of prophylactic surgery in the management of individuals with a hereditary cancer predisposition. Surg Clin N Am 88(4):739–758, vi Oseni T, Jatoi I (2008) An overview of the role of prophylactic surgery in the management of individuals with a hereditary cancer predisposition. Surg Clin N Am 88(4):739–758, vi
12.
Zurück zum Zitat Jatoi I, Benson JR (2013) The case against routine preoperative breast MRI. Future Oncol 9(3):347–353CrossRefPubMed Jatoi I, Benson JR (2013) The case against routine preoperative breast MRI. Future Oncol 9(3):347–353CrossRefPubMed
13.
Zurück zum Zitat Peralta EA, Ellenhorn JD, Wagman LD, Dagis A, Andersen JS, Chu DZ (2000) Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 180(6):439–445CrossRefPubMed Peralta EA, Ellenhorn JD, Wagman LD, Dagis A, Andersen JS, Chu DZ (2000) Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 180(6):439–445CrossRefPubMed
14.
Zurück zum Zitat Herrinton LJ, Barlow WE, Yu O et al (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23(19):4275–4286CrossRefPubMed Herrinton LJ, Barlow WE, Yu O et al (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23(19):4275–4286CrossRefPubMed
15.
Zurück zum Zitat Bedrosian I, Hu CY, Chang GJ (2010) Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 102(6):401–409CrossRefPubMedPubMedCentral Bedrosian I, Hu CY, Chang GJ (2010) Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 102(6):401–409CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Boughey JC, Hoskin TL, Degnim AC et al (2010) Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer. Ann Surg Oncol 17(10):2702–2709CrossRefPubMedPubMedCentral Boughey JC, Hoskin TL, Degnim AC et al (2010) Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer. Ann Surg Oncol 17(10):2702–2709CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Brewster AM, Bedrosian I, Parker PA et al (2012) Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer 118(22):5637–5643CrossRefPubMedPubMedCentral Brewster AM, Bedrosian I, Parker PA et al (2012) Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer 118(22):5637–5643CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Evans DG, Ingham SL, Baildam A et al (2013) Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer. Breast Cancer Res Treat 140(1):135–142CrossRefPubMed Evans DG, Ingham SL, Baildam A et al (2013) Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer. Breast Cancer Res Treat 140(1):135–142CrossRefPubMed
19.
Zurück zum Zitat Metcalfe K, Gershman S, Ghadirian P et al (2014) Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ 348:g226CrossRefPubMedPubMedCentral Metcalfe K, Gershman S, Ghadirian P et al (2014) Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. BMJ 348:g226CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Jatoi I, Parsons HM (2014) Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias. Breast Cancer Res Treat 148(2):389–396CrossRefPubMedPubMedCentral Jatoi I, Parsons HM (2014) Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias. Breast Cancer Res Treat 148(2):389–396CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Morrow M (2011) Prophylactic mastectomy of the contralateral breast. Breast 20(Suppl 3):S108–S110CrossRefPubMed Morrow M (2011) Prophylactic mastectomy of the contralateral breast. Breast 20(Suppl 3):S108–S110CrossRefPubMed
Metadaten
Titel
Bilateral Mastectomy for Unilateral Breast Cancer: a Perplexing Trend
verfasst von
Ismail Jatoi
Publikationsdatum
01.08.2015
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 4/2015
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-015-0450-8

Weitere Artikel der Ausgabe 4/2015

Indian Journal of Surgical Oncology 4/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.